ORMP — Oramed Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $171.80m
- $121.19m
- $2.00m
Oramed Pharmaceuticals Inc expected to post earnings of 43 cents a share - Earnings Preview
Brief: Oramed And Lifeward Announce Strategic Transaction
Brief: Oramed Receives $18 Million Payment From Scilex Holdings
Brief: Oramed Reports Fiscal Third Quarter 2025 Financial Results
Oramed Pharmaceuticals Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Oramed Pharmaceuticals Enters Option Agreement With Scilex For Warrant Repurchase
Brief: Oramed Pharmaceuticals Announces $36.9 Million Investment And Strategic Collaboration With Alpha Tau Medical
Oramed Pharmaceuticals Inc expected to post a loss of 2 cents a share - Earnings Preview
Oramed Pharmaceuticals Inc expected to post a loss of 2 cents a share - Earnings Preview
Oramed Pharmaceuticals Inc expected to post a loss of 2 cents a share - Earnings Preview
Oramed Pharmaceuticals Inc expected to post a loss of 2 cents a share - Earnings Preview
Oramed Pharmaceuticals Inc expected to post a loss of 2 cents a share - Earnings Preview
Brief: Oramed Announces Joint Venture To Develop And Commercialize Oral Insulin
Brief: Oramed Pharmaceuticals Inc - On Dec 13, Received $13.2 Million Payment From Scilex, Pursuant To Terms Of Tranche A Note
Oramed Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary
Oramed Pharmaceuticals Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: Oramed Pharmaceuticals Announces Restructuring Of Scilex Holding Company Debt
Oramed Pharmaceuticals Inc reports results for the quarter ended in January - Earnings Summary
Oramed Pharmaceuticals Inc expected to post earnings of 1 cent a share - Earnings Preview